Lobbying Filing Details

Total Spending

$190,000

Activities

1

Lobbyists

1

Gov't Entities

3

Filing Information
Filing UUID:
8f1a2165-2ff6-44c5-833d-11f3e6316d95
Type:
Q3 - 3rd Quarter - Report
Period:
2022 - 3rd Quarter (July 1 - Sep 30)
Date Posted:
October 20, 2022 at 2:55 PM
Income:
$0
Expenses:
$190,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Andrew Womack
Registrant
IGM BIOSCIENCES, INC.

​Development of engineered IgM antibodies

Mountain View, California
Client
IGM BIOSCIENCES, INC.
California, United States of America
Lobbying Activities (1)
Activity 1
Medical/Disease Research/Clinical Labs

COVID Supplemental Appropriation FY2023 Defense Appropriations S.2076/H.R.3932 - PASTEUR Act of 2021 S.3799 - PREVENT Pandemics Act Issues related to the development of an antibody therapy for COVID-19 Issues related to antimicrobial resistance (AMR) and drug development Issues related to supply chain and biopharmaceutical manufacturing H.R.8236 - Department of Defense Appropriations Act, 2023 H.R.7667 - Food and Drug Amendments of 2022 S.4348 - Food and Drug Administration Safety and Landmark Advancements Act (FDASLA) of 2022 H.R.5585 - Advanced Research Projects Agency - Health (ARPA-H) Act S.3819 - Advanced Research Project Authority for Health (ARPA-H) Act H.R.6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023

Lobbyists (1)
  • MR. ANDREW WESLEY WOMACK
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Health & Human Services, Dept of (HHS)

Source: LDA.gov, data retrieved November 11, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.